BLOCKADE OF INVIVO BINDING OF I-125-LABELED 3-IODOBENZAMIDE (IBZM) TO DOPAMINE-RECEPTORS BY D2 ANTAGONIST AND AGONIST

被引：12
|
作者：
SINGHANIYOM, W
TSAI, YF
BRUCKE, T
MCLELLAN, CA
COHEN, RM
KUNG, HF
CHIUEH, CC
机构：
[1] NIMH, CEREBRAL METAB LAB,CLIN BRAIN IMAGING SECT, BLDG 10,RM 2D-52, BETHESDA, MD 20892 USA
[2] UNIV PENN, DEPT RADIOL, PHILADELPHIA, PA 19104 USA
来源：
BRAIN RESEARCH | 1988年 / 453卷 / 1-2期
关键词：
D O I：
10.1016/0006-8993(88)90186-2
中图分类号：
Q189 [神经科学];
学科分类号：
071006 ;
摘要：
引用
收藏
页码：393 / 396
页数：4
相关论文
共 50 条
  • [41] Agonist signalling properties of radiotracers used for imaging of dopamine D2/3 receptors
    van Wieringen, Jan-Peter
    Michel, Martin C.
    Janssen, Henk M.
    Janssen, Anton G.
    Elsinga, Philip H.
    Booij, Jan
    EJNMMI RESEARCH, 2014, 4
  • [42] EFFECT OF 3-PPP, A PUTATIVE DOPAMINE AUTORECEPTOR AGONIST, ON [H-3]-LABELED LIGAND-BINDING TO DOPAMINE-RECEPTORS OF CALF AND RAT STRIATUM
    WONG, DT
    THRELKELD, PG
    REID, LR
    DRUG DEVELOPMENT RESEARCH, 1983, 3 (02) : 177 - 184
  • [43] SELECTIVE BLOCKADE OF DOPAMINE D-1 RECEPTOR BY SCH-23390 AFFECTS DOPAMINE AGONIST BINDING TO H-3-SPIPERONE LABELED D-2 RECEPTORS IN RAT STRIATUM
    ZHANG, X
    SEGAWA, T
    JAPANESE JOURNAL OF PHARMACOLOGY, 1989, 50 (03): : 333 - 345
  • [44] EFFECTS OF FLUORO-DOPAMINES ON DOPAMINE-RECEPTORS (D1, D2, D3 SITES)
    FIRNAU, G
    GARNETT, S
    MARSHALL, AM
    SEEMAN, P
    TEDESCO, J
    KIRK, KL
    BIOCHEMICAL PHARMACOLOGY, 1981, 30 (21) : 2927 - 2930
  • [45] Comparison of in vivo dopamine D2 receptor binding of [123I]AIBZM and [123I]IBZM in rat brain
    Li, HF
    Gildehaus, FJ
    Dresel, S
    Patt, JT
    Shen, MH
    Zhu, T
    Liu, BL
    Tang, ZG
    Tatsch, K
    Hahn, K
    NUCLEAR MEDICINE AND BIOLOGY, 2001, 28 (04) : 383 - 389
  • [46] In vivo measurement of haloperidol affinity to dopamine D2/D3 receptors by [123I]IBZM and single photon emission computed tomography
    Videbæk, C
    Toska, K
    Friberg, L
    Holm, S
    Angelo, HR
    Knudsen, GM
    JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 2001, 21 (01): : 92 - 97
  • [47] Dopamine D2 receptor binding is reduced in Wilson's disease: Correlation of neurological deficits with striatal I-123-Iodobenzamide binding
    Oder, W
    Brucke, T
    Kollegger, H
    Spatt, J
    Asenbaum, S
    Deecke, L
    JOURNAL OF NEURAL TRANSMISSION, 1996, 103 (8-9) : 1093 - 1103
  • [48] Oral bioavailability and brain penetration of (-)-stepholidine, a tetrahydroprotoberberine agonist at dopamine D1 and antagonist at D2 receptors, in rats
    Sun, Yan
    Dai, Jieyu
    Hu, Zheyi
    Du, Feifei
    Niu, Wei
    Wang, Fengqing
    Liu, Fei
    Jin, Guozhang
    Li, Chuan
    BRITISH JOURNAL OF PHARMACOLOGY, 2009, 158 (05) : 1302 - 1312
  • [49] IDENTIFICATION OF EXTRASTRIATAL DOPAMINE D2 RECEPTORS IN POSTMORTEM HUMAN BRAIN WITH [I-125] EPIDEPRIDE
    KESSLER, RM
    WHETSELL, WO
    ANSARI, MS
    VOTAW, JR
    DEPAULIS, T
    CLANTON, JA
    SCHMIDT, DE
    MASON, NS
    MANNING, RG
    BRAIN RESEARCH, 1993, 609 (1-2) : 237 - 243
  • [50] Ligand Binding Pathways of Clozapine and Haloperidol in the Dopamine D2 and D3 Receptors
    Thomas, Trayder
    Fang, Yu
    Yuriev, Elizabeth
    Chalmers, David K.
    JOURNAL OF CHEMICAL INFORMATION AND MODELING, 2016, 56 (02) : 308 - 321
12345